cerca CERCA
Mercoledì 21 Aprile 2021
Aggiornato: 06:58
Temi caldi

CHIMICA E FARMACEUTICA

Winhealth Pharma and TWiB Enter into Strategic Licensing Partnership on AC-203

SHANGHAI and TAIPEI, Jan. 7, 2021 /PRNewswire/ -- Hongkong Winhealth Pharma Group (Winhealth Pharma) and Taiwan TWi Biotechnology, Inc. (TWiB) announced strategic partnership granting Winhealth Pharma exclusive right to develop and commercialize rare disease asset AC-203 in mainland China, Hong Kong and Macao for indications including hereditary epidermolysis bullosa (EB), bullous pemphigoid and other skin diseases.

WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries

STOCKHOLM and HANGZHOU, China, Dec. 31, 2020 /PRNewswire/ -- Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti® (glycerol phenylbutyrate), in a territory covering the Greater China Area, South Korea, Singapore, Vietnam, Indonesia, Malaysia, Philippines and Thailand.

Plasticase/NANUK annuncia il nuovo direttore vendite e della strategia commerciale dell'EMEA

GRONINGEN, Paesi Bassi, 17 dicembre 2020 /PRNewswire/ -- Il Presidente e CEO di Plasticase Inc., José Chagnon e Herman Vaszlovsky, Amministratore Delegato di NANUK EU bv, hanno oggi annunciato la nomina di Ken Adriaenssens a Direttore Vendite e Strategia Commerciale dell'EMEA. Plasticase Inc. è il produttore di valigie protettive professionali NANUK con sede in Quebec, Canada.

Yiling Pharmaceutical: TCM Lianhua Qingwen Obtained Access to Zimbabwe

SHIJIAZHUANG, China, Dec. 17, 2020 /PRNewswire/ -- Yiling Pharmaceutical discloses on Wednesday that it has received the Approval of Registration approved and issued by the Medicines Control Authority of Zimbabwe, which indicates that the Company's patented product of "Lianhua Qingwen Capsules" meets Zimbabwe's registration standards for complementary medicine. 

Plasticase/NANUK Announces New EMEA Director of Sales and Commercial Strategy

GRONINGEN, The Netherlands, Dec. 15, 2020 /PRNewswire/ -- President and CEO of Plasticase Inc., José Chagnon and Herman Vaszlovsky, Managing Director of NANUK EU bv, today announced the appointment of Ken Adriaenssens as EMEA Director of Sales and Commercial Strategy. Plasticase Inc. is the Quebec, Canada-based manufacturer of NANUK Professional Protective Cases.

The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment for XLHED, a dermatologic-related rare genetic disease that requires prenatal therapeutic intervention

GENEVA and CASTRES , France, Dec. 14, 2020 /PRNewswire/ -- The EspeRare Foundation and the Pierre Fabre group announced today that they have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked Hypohidrotic Ectodermal Dysplasia), a rare, debilitating congenital disease. The next clinical study is expected to start in 2021 and will aim at qualifying and registering what may become the first appr...

LyondellBasell aderisce al Patto mondiale delle Nazioni Unite

HOUSTON, 11 dicembre 2020 /PRNewswire/ -- LyondellBasell (NYSE: LYB), una delle più grandi aziende al mondo nel settore delle materie plastiche, dei prodotti chimici e della raffinazione, ha annunciato oggi di aver aderito al Patto mondiale delle Nazioni Unite, la maggiore iniziativa di sostenibilità aziendale al mondo. I firmatari sono incoraggiati ad allineare attività e strategie ai principi chiave in materia di diritti umani, lavoro e lotta alla corruzione.

LyondellBasell joins the United Nations Global Compact

HOUSTON, Dec. 10, 2020 /PRNewswire/ -- LyondellBasell (NYSE: LYB) one of the world's largest plastics, chemicals and refining companies today announced it has joined the United Nations (U.N.) Global Compact, the world's largest corporate sustainability initiative. Under the U.N. Global Compact, signatories are encouraged to align their operations and strategies with key principles on human rights, labor and anti-corruption.

iX Biopharma receives positive EMA Scientific Advice for Wafermine(TM)

SINGAPORE, Dec. 8, 2020 /PRNewswire/ -- Specialty pharmaceutical company iX Biopharma Ltd (SGX:42C) ("iX Biopharma" or, "the Company") is pleased to announce that it has received positive feedback from the European Medicines Agency (EMA) in its scientific advice to the Company regarding its Phase 3 clinical development programme for Wafermine™, its sublingual ketamine wafer, for registration in Europe (the "EMA Scientific Advice").

Henlius Adalimumab Biosimilar Approved by NMPA

SHANGHAI, Dec. 8, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the adalimumab biosimilar HLX03, developed and manufactured by the Company independently, has been approved by the National Medical Products Administration (NMPA) for the treatment of rheumatoid arthritis (RA), ankylosing spondylitis (AS) and plaque psoriasis (Ps). It is the third monoclonal antibody (mAb) developed by Henlius and approved in China, after the Company's rituximab biosimilar HLX01, the fi...

Menarini Presenta i Risultati di Nuovi Studi Preclinici su MEN1611 per il Trattamento del Carcinoma Mammario al San Antonio Breast Cancer Symposium 2020

POMEZIA, Italia, 7 dicembre 2020 /PRNewswire/ -- Il Gruppo Menarini ha annunciato oggi che presenterà i risultati di due diversi studi preclinici su MEN1611, un inibitore potente e selettivo della fosfatidilinositolo 3-chinasi (PI3Ki) in sviluppo per il trattamento del carcinoma mammario, al prossimo San Antonio Breast Cancer Symposium, che si svolgerà virtualmente dal 8 al 11 dicembre 2020.

ora in
Prima pagina
Tag più usati
in questa pagina

change in emea region

executive

leadership

leadership change

partner di canale

prodotti imdsoft

servizi metavision

sistema informativo

articoli
in Evidenza